We are live on ! Find out more
MCM

Mitchell Capital Management Portfolio holdings

AUM $657M Turnover 18.9%
1-Year Est. Return 64.28%
This Fund
S&P 500
This Quarter Est. Return
-16.24%
1 Year Est. Return
+64.28%
3 Year Est. Return
+219.19%
5 Year Est. Return
+290.67%
10 Year Est. Return
+1,227.64%
AUM
$357M
AUM Growth
-$90M
Cap. Flow
-$9.59M
Cap. Flow %
-2.69%
Top 10 Hldgs %
34.57%
Holding
140
New
13
Increased
67
Reduced
32
Closed
20
Avg Time Held
2.9 years
Top 10 Avg Time Held
2.3 years
Top 20 Avg Time Held
2.4 years

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$3.4M
2
VRTX icon
Vertex Pharmaceuticals
VRTX
+$3.17M
3
VST icon
Vistra
VST
+$2.53M
4
CPRT icon
Copart
CPRT
+$2.19M
5
EXC icon
Exelon
EXC
+$2.12M

Sector Composition

Rank Sector Weight
1 Technology 24.83%
2 Healthcare 14.43%
3 Financials 11.78%
4 Miscellaneous 9.42%
5 Consumer Discretionary 8.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
MKSI icon
126
MKS Inc
MKSI
$14.5B
– –
-15,810
Closed -$2.37M –
RCL icon
127
Royal Caribbean
RCL
$74.3B
– –
-34,677
Closed -$2.9M –
TTE icon
128
TotalEnergies
TTE
$201B
– –
-17,452
Closed -$882K –
UBER icon
129
Uber
UBER
$144B
– –
-55,563
Closed -$1.98M –
VALE icon
130
Vale
VALE
$55.6B
– –
-58,589
Closed -$1.17M –
CERN
131
DELISTED
Cerner Corp
CERN
– –
-3,823
Closed -$358K –

Similar funds

Mitchell Capital Management's Q2 2022 Portfolio in Review

As of Q2 2022, Mitchell Capital Management held 140 positions worth $357M, down 20% from $447M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Mitchell Capital Management's Q2 2022 filing shows 13 new, 67 increased, 32 reduced and 20 closed positions. Its largest new stake was Vertex Pharmaceuticals: 11,826 shares worth $3.33M. The largest sale was DuPont de Nemours, an estimated $3.09M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 27% a quarter earlier, followed by Healthcare and Financials.

  • Mitchell Capital Management's largest Q2 2022 buy was Vertex Pharmaceuticals: 11,826 shares worth $3.33M.
  • Mitchell Capital Management added most to Johnson & Johnson in Q2 2022, an estimated $3.4M increase.
  • Mitchell Capital Management's biggest Q2 2022 reduction was Costco, cutting an estimated $2.05M.
  • Mitchell Capital Management fully exited DuPont de Nemours in Q2 2022, selling an estimated $3.09M.
  • Mitchell Capital Management's ten largest holdings make up 35% of its $357M portfolio in Q2 2022.
  • Mitchell Capital Management opened 13 new positions and closed 20 in Q2 2022.
  • Mitchell Capital Management's portfolio value fell 20% quarter-over-quarter to $357M.

Based on Mitchell Capital Management's 13F filing for Q2 2022, filed 29 Jul 2022.